Company Press Releases

Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of its SmoothX(R) Contrast Media Confirming Product Superiority, and announces Option Grant and AGM Date

2023-04-04 / @thenewswire

(TheNewswire)   Calgary, Alberta – TheNewswire - April 4, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") announces that it has completed comparative studies of SmoothX® versus Readi-Cat®2% with taste test and Compu...Read More

Voyageur Pharmaceuticals Ltd. Files Annual Audited Financial Statements

2023-03-30 / @thenewswire

(TheNewswire)   Calgary, AB - TheNewswire - March 30, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the "Company" or "Voyageur") announces that it has filed its annual audited financial statements and management's discussion and analysis for the year en...Read More

Viscount Mining/Centerra Gold Drills Bonanza Grade Silver in New Veins at Cherry Creek, Nevada

2023-02-28 / @newsfile

Including 1456 g/t over 1.5 Meters and 297 g/t over 5.0 MetersIdentified three vertically stacked Carbonate Replacement Deposit Horizons (CRD) type features and mineralized zones at the Ti-Cup targetVancouver, British Columbia--(Newsfile Corp. - February 28, 2023) - Viscount Mining Corp. (TSXV:...Read More

Voyageur Pharmaceuticals Ltd. Provides an Update and Prepares to Launch Initial Sales in Canada

2023-02-14 / @thenewswire

(TheNewswire)   Calgary, Alberta – TheNewswire - February 14, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") continues to advance its sales and marketing programs and is preparing to launch its first product, SmoothX™...Read More

SILVERCORP REPORTS Q3 FISCAL 2023 ADJUSTED NET INCOME OF $11.8 MILLION, $0.07 PER SHARE, AND ISSUES FISCAL 2024 PRODUCTION, CASH COSTS, AND CAPITAL EXPENDITURE GUIDANCE

2023-02-10 / @newswire

Trading Symbol:  TSX: SVM    NYSE AMERICAN: SVM        VANCOUVER, BC, Feb. 9, 2023 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reported its financial and operating results for...Read More

Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares for Debt

2023-01-27 / @thenewswire

(TheNewswire) Calgary, AB - TheNewswire - January 27, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the "Company" or "Voyageur") announces that, further to its news release dated December 2, 2022, it has issued a total of 125,322 Common Shares at a deemed price...Read More

Amended: Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement

2023-01-23 / @thenewswire

(TheNewswire)   Calgary, AB - TheNewswire - January 23, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the "Company" or "Voyageur") announces that, further to its news releases dated December 8 and 23, 2022 and January 12 and 20, 2023, the use of proceeds wi...Read More

Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement

2023-01-20 / @thenewswire

(TheNewswire)   Calgary, Alberta – TheNewswire - January 20, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") is pleased to announce that, further to its news releases dated December 8 and 23, 2022 and January 12, 2023, it h...Read More

Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement

2023-01-13 / @thenewswire

(TheNewswire)   News Release – TheNewswire - Calgary, Alberta – January 12, 2023: Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA: VYYRF) (the "Company" or "Voyageur") is pleased to announce that, further to its news releases dated December 6 and 23, 2022, and...Read More

SILVERCORP REPORTS OPERATIONAL RESULTS AND THE FINANCIAL RESULTS RELEASE DATE FOR THE THIRD QUARTER OF FISCAL 2023

2023-01-13 / @newswire

Trading Symbol:   TSX: SVM           NYSE AMERICAN: SVM VANCOUVER, BC, Jan. 13, 2023 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE: SVM) reports production and sales figures for the third quart...Read More

Voyageur Pharmaceuticals Ltd. Announces First Closing of Private Placement

2022-12-23 / @thenewswire

(TheNewswire)   News Release – Calgary, Alberta – TheNewswire - December 23, 2022: Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (the "Company" or "Voyageur") is pleased to announce that, further to its news release dated December 6, 2022, it has c...Read More

The Power Play by The Market Herald Releases New Interviews with Usha Resources, Voyageur Pharmaceuticals, ARway and Surge Battery Metals Discussing Their Latest News

2022-12-12 / @accesswire

VANCOUVER, BC / ACCESSWIRE / December 12, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Usha Resources, Voyageur Pharmaceuticals, ARway and Surge Battery Metals discussing their latest news.The Power Play by The Market Herald provides investors w...Read More

Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of SmoothX (TM) Barium Contrast Media & Financing

2022-12-08 / @thenewswire

(TheNewswire)   News Release – Calgary, Alberta –  TheNewswire - December 8, 2022: Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the "Company" or "Voyageur") announces that it has initiated its marketing campaign to introduce SmoothX™ bariu...Read More

Voyageur Pharmaceuticals Ltd. Announces Equity Incentive Compensation

2022-12-03 / @newsfile

Calgary, Alberta--(Newsfile Corp. - December 2, 2022) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) (the "Company" or "Voyageur") announces that it has issued 125,322 Deferred Share Units ("DSUs") to directors pursuant to its fixed 10% equity incentive compensation plan adopted by the...Read More

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Completed Production of a Test Batch of its SmoothX?,,? Barium Sulfate CT Contrast Media Oral Suspension for the Canadian CT Imaging Market

2022-11-29 / @GlobeNewswire

VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has completed production of a test batch of its SmoothX™ barium sulfate CT contrast media oral suspension for the CT imaging market in Canada. This production represents...Read More

The Power Play by The Market Herald Releases New Interviews with Trillion, Gamelancer, INEO Tech, ACME Lithium and Voyageur Discussing Their Latest News

2022-11-29 / @accesswire

VANCOUVER, BC / ACCESSWIRE / November 29, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Trillion, Gamelancer, INEO Tech, ACME Lithium and Voyageur discussing their latest news.The Power Play by The Market Herald provides investors with a quick sn...Read More

Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX (TM)

2022-11-28 / @thenewswire

(TheNewswire)   Calgary, Alberta – TheNewswire - November 28, 2022: Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") announces completion of the production test batch of its SmoothX™ barium sulfate CT contrast media oral suspe...Read More

SILVERCORP DECLARES SEMI-ANNUAL DIVIDEND OF US$0.0125 PER SHARE AND REPORTS THE FILING OF AN UPDATED TECHNICAL REPORT FOR THE YING MINING DISTRICT

2022-11-07 / @newswire

Trading Symbol: TSX/NYSE American: SVM VANCOUVER, BC, Nov. 7, 2022 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) is pleased to announce that its Board of Directors have declared a semi-annual dividend of US$0.0125 per share...Read More

SILVERCORP REPORTS ADJUSTED NET INCOME OF $6.7 MILLION, $0.04 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $14.1 MILLION FOR Q2 FISCAL 2023

2022-11-03 / @newswire

VANCOUVER, BC, Nov. 3, 2022 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reported its financial and operating results for the three months ended September 30, 2022 ("Q2 Fiscal 2023"). All amounts are expressed in US d...Read More

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems

2022-10-26 / @GlobeNewswire

VANCOUVER, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has signed a memorandum of understanding with Rain Cage Carbon to develop fullerene-based contrast agents. Rain Cage Carbon, a private carbon capture company located in Calgary...Read More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok